Rhumbline Advisers Neogenomics Inc Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Neogenomics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 388,405 shares of NEO stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
388,405
Previous 366,589
5.95%
Holding current value
$3.51 Million
Previous $3.48 Million
18.37%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$178 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$128 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$67.1 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$61.8 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$46.2 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.14B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...